Benign thyroid nodules in pediatric patients: determining best practices for repeat ultrasound evaluations

Juanita K Hodax1, Kimberly Bowerman2, Jose Bernardo Quintos1

  • 1Department of Pediatrics, Division of Endocrinology and Diabetes, Hasbro Children's Hospital, Providence, RI, USA.

Insights

Pediatric thyroid nodules with benign fine needle aspiration (FNA) cytology require tailored follow-up. Repeat ultrasound evaluation at one year is recommended for low-risk children to monitor nodule growth and detect potential malignancy.

Area of Science:

  • Pediatric Endocrinology
  • Thyroidology
  • Oncology

Background:

  • Current American Thyroid Association (ATA) guidelines for benign thyroid nodules in children rely on adult data.
  • Significant physiological differences exist between pediatric and adult thyroid nodules.
  • Optimal follow-up intervals for pediatric benign thyroid nodules require specific investigation.

Purpose of the Study:

  • To determine the appropriate follow-up schedule for pediatric patients with benign thyroid nodules diagnosed via fine needle aspiration (FNA).
  • To evaluate the growth patterns and outcomes of benign thyroid nodules in children.

Main Methods:

  • Retrospective chart review of patients under 19 years old diagnosed with benign thyroid nodules via FNA between 2003 and 2013.
  • Analysis of initial and follow-up ultrasound findings, nodule size, and patient demographics.
  • Review of surgical pathology results for patients who underwent thyroidectomy.

Main Results:

  • 43 pediatric patients with benign FNA cytology were identified; average age 15.6 years, 91% female.
  • Initial ultrasound characteristics included average nodule size of 2.5 cm, with varying rates of calcifications, hyperemia, hypoechogenicity, and lymphadenopathy.
  • Four patients showed significant nodule growth; one patient with papillary thyroid carcinoma (PTC) initially had a decreasing nodule size before increasing over 4.5 years. 33% of nodules were surgically removed, with final pathology revealing benign cytology, follicular adenoma, or PTC.

Conclusions:

  • Most pediatric benign thyroid nodules do not exhibit significant growth within the first year.
  • A follow-up ultrasound at one year is suggested for low-risk pediatric patients with benign thyroid nodule cytology.
  • This approach aids in monitoring nodule behavior and timely detection of potential malignancies like PTC.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
269
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
198
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.8K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.0K